The rising interest in GLP-1 agonists for diabetes has sparked a discussion about delivery routes : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were exclusively available in oral https://haarisvhlv632703.blogaritma.com/38855469/glp-1-transdermal-delivery-systems-vs-oral-medications-which-suitable-for-the-patient